期刊文献+

两性霉素B治疗新型隐球菌性脑膜炎疗效观察 被引量:3

Clinical Observation of Amphotericin B for the Treatment of Cryptococcosis Meningitis
下载PDF
导出
摘要 【目的】观察两性霉素B(AMB)治疗新型隐球菌性脑膜炎(隐脑)的临床疗效及不良反应。【方法】将22例隐脑患者给予AMB静脉滴注,部分患者加以AMB鞘内注射,按标准评定疗效和不良反应。【结果】有效率72.7%,不良反应种类多且较严重。【结论】AMB对于隐脑疗效显著,虽然副作用明显,但仍可作为治疗隐脑的首选药物。 [Objective] To observe the clinical effect and adverse reaction of amphotericin B for the treatment of Cryptocoecosis meningitis. [Methods] Twenty two patients with Amphotericin B were given by intravenous drip and partly by intrathecal injection. The effect and adverse reaction were evaluated according to standards. [Results] The effective rate was 72.7 %, and the adverse reactions were varied and severe. [Conclusion] Amphotericin B is very effective for Cryptococeosis meningitis. Even though its toxicity is severe, it is still the preferred drug.
出处 《医学临床研究》 CAS 2008年第4期682-684,共3页 Journal of Clinical Research
关键词 两性霉素B/治疗应用 脑膜炎 隐球菌性/药物疗法 隐球菌 新型 amphotericin B/TU meningitis, cryptococcal/DT cryptococcus neoformans
  • 相关文献

参考文献3

二级参考文献12

共引文献12

同被引文献36

引证文献3

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部